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We report a case of biliary adenofibroma with an invasive carcinoma in a 71-year-old female who presented with bilateral upper
abdominal pain. Imaging revealed a 6.3 cm heterogeneously enhancing mass in the left lateral segment of the liver. Histologically,
the adenofibroma showed the characteristic components as previously described of biliary adenofibromata, namely, cystic and
tubular structures lined by cuboidal to low columnar biliary type epithelium and a dense fibrous stroma composed of spindled cells.
Intimately admixedwith the adenofibromawas a distinct tumor composed ofmalignant clear cells which demonstrated stromal and
vascular invasion. Although mitotic figures were inconspicuous, Ki67 was brisk and p53 demonstrated 25–50% positivity. Sections
also showed a von Meyenberg complex located adjacent to the tumor. This case expands the understanding of this rare tumor
and proves two important assertions from previous case reports. First, the presence of an associated von Meyenberg complex
with similar morphology and immunohistochemical staining pattern suggests that biliary adenofibromata and von Meyenberg
complexes may share related histogenesis. Second, biliary adenofibromata harbor malignant potential and may show malignant
transformation. Furthermore, this case highlights the need for these rare tumors to be followed aggressively, as their biological
behavior is poorly understood.
1. Introduction
Biliary adenofibromata are extremely rare tumors with
unknown etiology and previously uncertain malignant
potential. The tumor was first described by Tsui et al. in 1993
and since then nine cases have been reported in the medical
literature. Biliary adenofibromata are characterized by cystic
and tubular biliary epithelial components surrounded by a
bland fibroblastic spindled stroma [1]. The tumors bear a
striking resemblance to bile duct hamartomas (von Meyen-
berg complexes); a similarity that has been noted in all
previously reported cases in the medical literature. Until this
report, vonMeyenberg complexes have not been identified in
histologic sections of tumor or adjacent uninvolved liver.
2. Case Report
A 71-year-old Caucasian female presented with chest pain.
Her subsequent workup included a chest CT which revealed
a 6.3 cm mass in the right aspect of the left lateral liver
straddling segments 2, 3, and 4a. The tumor was best
visualized in the precontrast and arterial phases. Contrast
enhancement was heterogeneous throughout the mass with
multiple areas of low attenuation. Of note, a PET scan showed
a 1.9 cm hypermetabolic focus within a 4.3 cm tumor. The
patient reported bilateral upper abdominal pain but denied
any nausea, vomiting, and weight loss or gain during this
period. She had no jaundice, change in bowel habits, or
gastrointestinal bleeding. There was no history of significant
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Figure 1: Tumor and surrounding liver parenchyma.
Figure 2: Conventional biliary adenofibroma, H&E 4x.
alcohol or intravenous drug use. The patient had no history
of transfusions. She denied personal or family history of
liver or biliary disease. Laboratory tests revealed normal liver
function testing, serum alpha fetoprotein, CEA, and CA19-
9. A biopsy was performed and showed biliary epithelium
arranged in cysts and tubules with a fibrotic/spindled stroma.
Subsequently, the patient underwent a left hepatectomy.
Intraoperative palpation of the abdominal cavity revealed no
signs of carcinomatosis.There were no postoperative compli-
cations. The patient reported no symptoms after surgery.
2.1. Macroscopic Findings. The partial lobectomy from the
left lobe contained a circumscribed tumor measuring 5.7 cm
that abutted and appeared to invade the liver capsule. The
cut surface revealed a smooth tan-white surface with subtle
variegation in color and firmness. Small cystic spaces were
noted throughout the tumor (Figure 1). The surrounding
hepatic parenchyma was unremarkable.
2.2. Microscopic Findings. The tumor showed tubulocystic
structures embedded in a bland spindled stroma, consistent
with a conventional biliary adenofibroma (Figure 2). A
distinct carcinomatous component was identified showing
solid, glandular, and papillary architecture. The malignant
component showed an infiltrative border with invasion
into the liver capsule and additionally showed penetration
into surrounding adhesions and skeletal muscle. Perineu-
ral tumor infiltration, intravenous invasion, and single cell
stromal invasion were seen. The tumor was focally seen in
Figure 3: Infiltrative border of tumor to surrounding liver,H&E 10x.
the adventitia of a large outflow vein. Although the tumor
appeared grossly circumscribed, microscopic examination
showed infiltrative margins (Figure 3).The cells of the malig-
nant component showed vacuolated cytoplasmwith centrally
placed nuclei.
To rule out metastasis from adrenal or renal primary
sites, inhibin and PAX8 immunohistochemistries were per-
formed and were negative. A cytokeratin 7 and cytokeratin
19 showed strong positivity in the bland tubulocystic areas
of conventional biliary adenofibroma and a lesser degree
of positivity in the solid and papillary carcinomatous areas.
CD56 stained scattered single cells, similar to the reactivity of
the ductular reaction in surrounding nontumor liver. A Ki-67
was uniformly brisk, despite inconspicuous mitotic figures.
P53 showedmoderate (25–50%) positivity in the tumor. Both
Ki67 and p53 were negative in the stromal component. CD10
and polyclonal CEA failed to show either cytoplasmic or
canalicular reactivity in tumor cells.
A vonMeyenberg complex was seen in hepatic parenchy-
ma adjacent to the tumor.
3. Discussion
These cases report the tenth biliary adenofibroma in the
medical literature, although two previous reports both from
Turkey report identical tumor and patient characteristics and
most likely represent the same tumor [2, 3].The tumor shows
a tubulocystic component with a bland spindled stroma, as
originally described by Tsui et al. in the first description of
biliary adenofibromata. At that time, the similarity to von
Meyenberg complexes was observed. Furthermore, bile pig-
ment in the tumor ducts implied a direct continuity with the
biliary system. Parada et al. reported monosomy 22 in a case
of biliary adenofibroma in a 49-year-old woman. However,
this findingwas not consistently found in a subsequent report
[4].
Malignant transformation of biliary adenofibromata has
been described in two previous cases. Akin described a 25-
year-old male who demonstrated a recurrent biliary ade-
nofibroma with pulmonary metastasis two years after initial
resection. However, histologic findings of the malignant
transformation were not described. Nguyen et al. described
a biliary adenofibroma with multiple foci of epithelial atypia,
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Table 1: Clinical and pathologic features of biliary adenofibromata reported in the literature.
Year Age/sex Tumor size Ki67% Associatedmalignancy Follow-up
Tsui et al. [1] 1993 74/F 7 cm Not performed No
Parada et al. [9] 1997 49/F 7 cm Not performed No
Akin and Coskun [2] 2002 25/M 20 cm Not performed Yes
Pulmonary
metastasis 3 years
after initial
diagnosis
Haberal et al. [3] 2001 21/M 25 cm Not performed No
Gardun˜o-Lo´pez [10] 2002 68/F 6 cm Not performed No 50-monthfollow-up
Varnholt et al. [4] 2003 47/F 16 cm
Ki67: low
stromal
component
negative
No 3-year follow-up
Gurrera et al. [11] 2010 79/M 5.5 cm Ki67 1% stromaland epithelial No
7-year
follow-up
Kai et al. [5] 2012 40/M 7 cm Ki67 5–10%
Unclassified
multicystic
biliary tumor
Nguyen et al. [6] 2012 53/F 6.5 cm Not performed Yes
12-month
follow-up no
recurrence
Godambe et al.
(present case) 2013 71/F 5.7 cm
Ki67 50% epithelial
component Yes
Figure 4: Conventional biliary adenofibroma, CK7, 10x.
including cytologic atypia and architectural atypia (crib-
riforming), representing high-grade dysplasia. They noted
a microinvasive carcinoma (<1mm) with increased atypia,
including mildly enlarged epithelial cells with prominent
nucleoli, a rare single cell in the stroma, and disrupted glands
that merged with sclerotic stroma.
Our malignant component shows distinct histology and
demonstrates nearly solid architecture. Immunohistochem-
ical findings showed variable reactivity between the benign
and malignant components. The bland tubulocystic glands
of the conventional biliary adenofibroma stained strongly
and homogeneously positive for cytokeratins 7 and 19, while
the carcinomatous areas showed weaker and more variable
staining for these cytokeratins (Figures 4 and 5). P53 has been
Figure 5: Invasive carcinoma, CK7, 10x.
reported in varying rates of positivity ranging from negative
to 75% of cells displaying strong nuclear staining; however,
case reports of biliary adenofibroma with malignant trans-
formation have not included a description of p53 staining
pattern [2, 3, 5, 6].
Although the origin of biliary adenofibromata is uncer-
tain, there is undeniable histologic and immunohistochemi-
cal similarity to von Meyenberg complexes. Tsui et al. noted
the resemblance to Meyenberg’s complex; however, they
described an absence of typical von Meyenberg complexes in
the background liver. Varnholt et al. reported a case of biliary
adenofibroma and furthermore characterized the tumoral
glandular epithelium staining positive for D10, p53 (50–75%
of the cells), keratin AE.3/Cam 5.2, cytokeratin 7, cytokeratin
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19, carcinoembryonic antigen, and epithelial membrane anti-
gen.They further noted that the epithelial lining did not stain
for IF6. Bile duct adenomas and peribiliary glands express
foregut antigens, designated D10 and IF6, and the secretion
of acid mucins. (Normal bile ductules and canals of Hering
demonstrate positivity for IF6 but notD10, whereas larger bile
ductsmay demonstrateD10 positivity in 22%of cases, with an
absence of IF6 [7].)
A similar pattern of D10 positivity/IF6 negativity was
reported in one bile duct hamartoma. Thus, Varnholt et al.
concluded that although the origin of biliary adenofibroma
is unknown, the epithelial expression of D10 but not IF6
suggests an origin similar to bile duct hamartoma [4].
von Meyenberg complexes are largely considered benign
and indolent; however, neoplastic transformation has been
rarely reported.Themost commonmalignancy arising in the
setting of ductal plate malformations (including von Meyen-
berg complexes, biliary cystic lesions, and congenital hepatic
fibrosis) is cholangiocarcinoma. Hepatocellular carcinomas,
adenosquamous carcinomas, squamous cell carcinomas, and
papillomas have also been reported [8]. The carcinoma seen
in our case is difficult to classify precisely; however, it shows
unequivocal features of malignancy. A summary of published
tumor characteristics is included in Table 1.
This case of biliary adenofibromawith invasive carcinoma
significantly expands the understanding of this rare tumor.
While the presence of a von Meyenberg complex in liver
adjacent to tumor does not prove the cellular origin of the
tumor, the identification of a vonMeyenberg complex in sec-
tions adjacent to tumor supports the observation that these
tumors may share similar histogenesis as its immunomor-
phologic counterpart. Despite previous case reports describ-
ing a malignant transformation, biliary adenofibromata are
currently generally regarded as benign entities. It is clear
that they harbor potential for malignant transformation and
therefore should be considered a premalignant tumor. P53
immunohistochemical stain has been performed in multiple
cases in an effort to predict biological behavior. While the
stromal component is consistently negative, the epithelial
component demonstrates wide variability in staining and
perhaps provides a mechanism to stratify risk of malignant
transformation. As these tumors are poorly understood,
patients require close clinical follow-up and observation.
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